Arthroplasty

Genesis Software Innovations Announces FDA 510(k) Clearance For Preview™ 3D Shoulder Arthroplasty Planning Software

Retrieved on: 
Wednesday, May 5, 2021
Medical specialties, Surgery, Clinical medicine, Orthopedic surgery, Arthroplasty, Orthopedics, Prosthetics, EOS imaging

b'GRAND RAPIDS, Mich., May 5, 2021 /PRNewswire/ --Genesis Software Innovations "GSI," a company that has created an innovative foundational platform solution in the orthopedic space, announced today that they have received FDA clearance for their PreView 3D Shoulder Arthroplasty Planning Software.

Key Points: 
  • b'GRAND RAPIDS, Mich., May 5, 2021 /PRNewswire/ --Genesis Software Innovations "GSI," a company that has created an innovative foundational platform solution in the orthopedic space, announced today that they have received FDA clearance for their PreView 3D Shoulder Arthroplasty Planning Software.
  • The PreView Shoulder Software is a breakthrough tool for orthopedic surgeons to develop pre-operative shoulder plans based on CT imaging studies.
  • PreView software allows surgeons to perform surgical planning by showing a representation of the patient\'s shoulder anatomy as a 3D model, allowing the digital placement of the implant into the patient\'s anatomy.
  • "\nThe PreView software will be available in the coming month.\nGenesis Software Innovations "GSI" is a software development company that designs and commercializes innovative medical-related software products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system.\nTheir foundational PreView 3D Shoulder Arthroplasty Planning Software is a breakthrough tool in pre-operative surgical planning.

Pixee Medical Receives FDA Clearance for Knee+

Retrieved on: 
Wednesday, April 28, 2021
Biotechnology, Surgery, Health, FDA, Medical devices, Technology, Other Technology, Other Health, Surgery, Medical specialties, Clinical medicine, Orthopedic surgery, Knee replacement, Arthroplasty, Knee

b'Pixee Medical , a pioneer in digitally augmented surgery technology, announces that its Knee+ AR computer assisted orthopedic solution has received 510(k) clearance from the U.S. Food and Drug Administration.\nThis press release features multimedia.

Key Points: 
  • b'Pixee Medical , a pioneer in digitally augmented surgery technology, announces that its Knee+ AR computer assisted orthopedic solution has received 510(k) clearance from the U.S. Food and Drug Administration.\nThis press release features multimedia.
  • Pixee Medical began commercialization in Europe and Australia in January 2021 and was surprised by just how quickly its product was adopted, with more than 60 systems sold in Q1.
  • We plan to quickly expand our platform to perform hip and shoulder replacements\xe2\x80\x9d states S\xc3\xa9bastien Henry, Founder and CEO of Pixee Medical.
  • Pixee Medical\xe2\x80\x99s augmented surgery platform is commercially available in Europe, Australia, and the USA for total knee arthroplasty with Knee+.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210428005803/en/\n'

Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System

Retrieved on: 
Wednesday, April 28, 2021
Biotechnology, FDA, Surgery, Medical devices, Health, Arthritis, Arthroplasty, Reverse shoulder replacement

We feel the Archer product family name represents these tenets well in the market place.\xe2\x80\x9d\nRecently, Catalyst announced 510(k) clearance of the Archer R1 Reverse Shoulder System, expanding its product portfolio with multiple arthroplasty options.

Key Points: 
  • We feel the Archer product family name represents these tenets well in the market place.\xe2\x80\x9d\nRecently, Catalyst announced 510(k) clearance of the Archer R1 Reverse Shoulder System, expanding its product portfolio with multiple arthroplasty options.
  • Catalyst\xe2\x80\x99s reverse shoulder system is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design.
  • Since its introduction in 2016, Catalyst\xe2\x80\x99s Archer CSR system has experienced explosive adoption and growth.
  • The Archer CSR system is unique, offering precision and accuracy in shoulder restoration while preserving the patient\xe2\x80\x99s bone and soft tissue.

Exactech Shares Industry’s First Shoulder Replacement Surgery “Smart Score” Metric Based on Machine Learning

Retrieved on: 
Tuesday, April 27, 2021
Technology, Research, Surgery, Medical devices, Software, Practice Management, Biotechnology, Health, Science, Surgery, Medical specialties, Clinical medicine, Prosthetics, Arthritis, Orthopedic surgery, Joint replacement, Shoulder replacement, Arthroplasty

b'Exactech , a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today the first orthopaedic clinical outcomes measure based on machine learning.

Key Points: 
  • b'Exactech , a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today the first orthopaedic clinical outcomes measure based on machine learning.
  • The Shoulder Arthroplasty Smart (SAS, or \xe2\x80\x9cSmart\xe2\x80\x9d) Score quantifies clinical outcomes for shoulder arthroplasty patients so surgeons can determine how well patients are doing before and after surgery.
  • View the full release here: https://www.businesswire.com/news/home/20210427005398/en/\nExactech Shares Industry\xe2\x80\x99s First Shoulder Replacement Surgery \xe2\x80\x9cSmart Score\xe2\x80\x9d Metric Based on Machine Learning (Photo: Business Wire)\nUnlike existing scores available in the industry, the Smart Score offers surgeons a more efficient means of measuring patient outcomes by requiring only half the inputs of other scores.
  • With just six patient-specific inputs, determined through machine learning research to be the most significant assessments of post-operative outcomes, the Smart Score (ranging from 0-100) is determined for each patient.

LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study

Retrieved on: 
Tuesday, April 20, 2021
Medical specialties, Pharmaceutical industry, Health sciences, Medicine, Arthritis, Investigational device exemption, Arthroplasty, Reverse shoulder replacement, IDE, Clinical trial

b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.

Key Points: 
  • b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.
  • This randomized, multi-center comparative clinical trial is currently evaluating the safety and effectiveness of the SMR Stemless Reverse Shoulder System compared to the SMR Reverse Shoulder System, in total reverse shoulder arthroplasty.
  • FDA approval of the SMR Stemless Reverse Shoulder System IDE was obtained in November 2020 and patient enrollment began in April 2021.
  • LimaCorporate\'s IDE study on SMR Stemless Reverse System is a pivotal first step to address this unmet need in the U.S. shoulder arthroplasty market.

LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study

Retrieved on: 
Tuesday, April 20, 2021
Medical specialties, Pharmaceutical industry, Health sciences, Medicine, Arthritis, Investigational device exemption, Arthroplasty, Reverse shoulder replacement, IDE, Clinical trial

b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.

Key Points: 
  • b'SAN DANIELE DEL FRIULI,Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.
  • This randomized, multi-center comparative clinical trial is currently evaluating the safety and effectiveness of the SMR Stemless Reverse Shoulder System compared to the SMR Reverse Shoulder System, in total reverse shoulder arthroplasty.
  • FDA approval of the SMR Stemless Reverse Shoulder System IDE was obtained in November 2020 and patient enrollment began in April 2021.
  • LimaCorporate\'s IDE study on SMR Stemless Reverse System is a pivotal first step to address this unmet need in the U.S. shoulder arthroplasty market.

LimaCorporate Announces the Successful Completion of the First Total Shoulder Arthroplasty Using the Smart Space Cubit Intraoperative Guidance System

Retrieved on: 
Thursday, April 1, 2021
Arthritis, Arthroplasty, Biblical mile, Measurement, Units of measurement, Shoulder, Days of the week

On March 25, 2021 Shelden Martin, MD performed the first successful total shoulder arthroplasty in Scottsdale, AZ using the Smart SPACE 3D Virtual Planner and the Shoulder Cubit Guidance digital platform.

Key Points: 
  • On March 25, 2021 Shelden Martin, MD performed the first successful total shoulder arthroplasty in Scottsdale, AZ using the Smart SPACE 3D Virtual Planner and the Shoulder Cubit Guidance digital platform.
  • Upon completion of the procedure Dr. Martin stated that, "I am very pleased that our first shoulder arthroplasty utilizing Smart SPACE Cubit Guidance went extremely well.
  • The Smart SPACE 3D Virtual Planner and Shoulder Cubit Guidance are innovative and fundamental cornerstones of the Smart SPACE ecosystem.
  • Luigi Ferrari, LimaCorporate CEO, stated: "The successful completion of the first Shoulder Cubit guided surgery is a significant milestone in Digital Transformation at LimaCorporate and signals the completion of the first phase of the Smart SPACE roadmap.

LimaCorporate Announces the Successful Completion of the First Total Shoulder Arthroplasty Using the Smart Space Cubit Intraoperative Guidance System

Retrieved on: 
Thursday, April 1, 2021
Arthritis, Arthroplasty, Biblical mile, Measurement, Units of measurement, Shoulder, Days of the week

On March 25, 2021 Shelden Martin, MD performed the first successful total shoulder arthroplasty in Scottsdale, AZ using the Smart SPACE 3D Virtual Planner and the Shoulder Cubit Guidance digital platform.

Key Points: 
  • On March 25, 2021 Shelden Martin, MD performed the first successful total shoulder arthroplasty in Scottsdale, AZ using the Smart SPACE 3D Virtual Planner and the Shoulder Cubit Guidance digital platform.
  • Upon completion of the procedure Dr. Martin stated that, "I am very pleased that our first shoulder arthroplasty utilizing Smart SPACE Cubit Guidance went extremely well.
  • The Smart SPACE 3D Virtual Planner and Shoulder Cubit Guidance are innovative and fundamental cornerstones of the Smart SPACE ecosystem.
  • Luigi Ferrari, LimaCorporate CEO, stated: "The successful completion of the first Shoulder Cubit guided surgery is a significant milestone in Digital Transformation at LimaCorporate and signals the completion of the first phase of the Smart SPACE roadmap.

DJO Invests in Next-Generation Augmented Reality Technology Primed for ASC Market Growth

Retrieved on: 
Tuesday, March 30, 2021
Surgery, Medical devices, Hospitals, Health, Managed care, Medical specialties, Marketing, User interface techniques, Clinical medicine, Applications of computer vision, Augmented reality, Prosthetics, Arthroplasty, Computer-assisted surgery, Joint replacement, DJO®, Insight Medical Systems

Unlike other augmented reality (AR) platforms, ARVIS is the first system with proprietary hardware designed to assist arthroplasty surgeons in enhancing component positioning precision to improve joint arthroplasty outcomes.

Key Points: 
  • Unlike other augmented reality (AR) platforms, ARVIS is the first system with proprietary hardware designed to assist arthroplasty surgeons in enhancing component positioning precision to improve joint arthroplasty outcomes.
  • View the full release here: https://www.businesswire.com/news/home/20210330005381/en/
    ARVIS Next-Generation Augmented Reality System (Photo: Business Wire)
    The Computer Assisted Surgery (CAS) Technology market is growing at a compound annual growth rate (CAGR) of 32%1.
  • DJO and Insight have a shared vision of improving clinical outcomes with technology in a streamlined, cost-effective way.
  • It is leveraging augmented reality technology to provide a highly cost effective and easy-to-use alternative to surgical navigation systems and robots.

Industry Stakeholders in Hip Replacement Implants Market Aim at Implant Modifications to Improve Outcomes in Total Hip Arthroplasty (THA): TMR

Retrieved on: 
Thursday, March 18, 2021
Surgery, Medical specialties, Medicine, Prosthetics, Hip replacement, Arthroplasty, Oxinium, Knee replacement

Modifications in hip replacement implants have thus gained groundswell of attention for implant manufacturers and healthcare teams.

Key Points: 
  • Modifications in hip replacement implants have thus gained groundswell of attention for implant manufacturers and healthcare teams.
  • In recent decades, such product advancements have gathered momentum on back of growing demand for total hip arthroplasty (THA).
  • Other factors such as advancements in surgical techniques and the focus on reducing the revision rates have all contributed to the evolution of the hip replacement implants market.
  • Growing number of hip reconstruction procedures is expected to propel the hip replacement implants market.